References
- Debbag R. Flu infection. Risks, complications and prevention. Rev. Esp. Cardiol. 4(Suppl.), 3G–6G (2004).
- Hansson, Göran K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695 (2005).
- Gurfinkel E, Fareed J, Antman E, Cohen M, Mautner B. The rationale for the management of acute coronary syndromes with low molecular weight heparins. Am. J. Cardiol. 82, L15–L18 (1998).
- Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA 276, 811–815 (1996).
- Shomig A, Neumann FJ, Kastrati A et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N. Engl. J. Med. 334, 1084–1089 (1996).
- Gurfinkel E, Bozovich G. Chlamydia pneumoniae, inflammation and the instability of the atherosclerotic plaque. Atherosclerosis 140(Suppl. 1), S31–S35 (1998).
- Vilariño JO, Esper R, Badimon JJ. Pathophysiology of acute coronary syndromes, three paradigms for a new dogma. Rev. Esp. Cardiol. 4(Suppl.), 13G–24G (2004).
- Moreno PR, Fallon JT. Inflammation in acute coronary syndromes. In: The Role of Immune Mechanisms in Cardiovascular Disease. Schultheiss H, Schwimmbeck P (Eds). Springer, Berlin, Germany. 213–229 (1997).
- Ameriso S, Ruiz Villamil A, Perez Barreto M et al. Infection, inflammation and stroke, Rev. Esp. Cardiol. 4(Suppl.), 7G–12G (2004).
- Nieto FS. Infections and atherosclerosis: new clues from an old hypothesis? Am. J. Epidemiol. 148, 937–947 (1998).
- PérezBarreto M, Fischberg GM, Paganini-Hill A et al. Low-dose endotoxin reduces human cerebrovascular reactivity and produces procoagulant state. Stroke 32, 360 (2001).
- Macko RF, Ameriso SF, Gruber A et al. Impairments of the protein C system and fibrinolysis in infections associated stroke. Stroke 27, 2005–2011 (1996).
- Saikku P. Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: the initial serologic observation and more. Review. J. Infect. Dis. 181(Suppl. 3), S411–S413 (2000).
- Fabricant CG, Fabricant J, Litrenta MM et al. Virus-induced atherosclerosis. J. Exp. Med. 148, 335–340 (1978).
- Dimaguya P, Cercek B, Oguchi S et al. Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in rag-1 knockout mice. Arterioscler. Thromb. Vasc. Biol. 22, 644–649 (2002).
- Caliguri G, Nicolettei A, Poirier B et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109, 721–724 (2002).
- Gurfinkel E, Rozlosnik J, Bozovich G et al. IgG antibodies to Chlamydia and Mycoplasma infection plus C-reactive protein re lated to poor clinical outcome in unstable angina, Arch. Inst. Mex. Cardiol. 67, 462–468 (1997).
- Gurfinkel E, Bozovich G, Daroca A, Beck G, Mautner B for the Roxis Study Group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. Lancet 350, 404–407 (1997).
- Gurfinkel E, Bozovich G, Livellara G, Beck E, Testa E, Mautner B. Antibiotics for the treatment of non-Q wave Coronary Syndromes. The Final Report of the ROXIS Trial. Eur. Heart J. 20, 121–127 (1999).
- Grayston JT, Kronmal RA, Jackson LA et al. Azithromycin for the secondary prevention of coronary events, N. Engl. J. Med. 352, 1637–1645 (2005).
- Cannon CP, Braunwald E, McCabe CH et al. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome, N. Engl J. Med. 352, 1646–1654 (2005).
- Naghavi M, Barlas Z, Siadaty S et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 102, 3039–3045 (2000).
- Lavallee P, Perchaud V, Gauier-Bertrand M et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 33, 513–518 (2002).
- Gurfinkel E, Leon de la Fuente R, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions : the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 105, 2143–2148 (2002).
- Gurfinkel E. The Fluvacs trial in perspective. Rev. Esp. Cardiol. 4(Suppl.), 25G–34G (2004).
- Gurfinkel E et al. National consensus on strategies in primary and secondary prevention of cardiovascular diseases through the application of antiflu vaccine, Rev. Esp. Cardiol. 4(Suppl.), 35G–41G (2004).
- AndersonJeffrey LMD. Infection, antibiotics, and atherothrombosis – end of the road or new beginnings? N. Engl. J. Med. 352, 16 (2005).
Websites
- Resolution from the Argentina Senate 18/march/2004: Health and Sports www.proyectos.senado.gov.ar/web/owa/ web_proce.verexpediente (Not accessed)
- Recomendations from the American Committee of Immunizations www.who.int/disease/flu/index.html